碘摄入增加对血清促甲状腺激素的影响:一项中国全国性横断面研究
基于中国全国代表性横断面研究(TIDE研究,78,470人),参考人群血清TSH几何均数为2.28 mIU/L(2.5th-97.5th:0.74-7.04 mIU/L),总人群为2.34 mIU/L(0.61-8.33 mIU/L)。参考人群中尿碘浓度升高与TSH第50和第97.5百分位升高、第2.5百分位降低显著相关。按试剂推荐区间(Roche 0.27-4.2 mIU/L)诊断的亚临床甲减患病率为13.61%,显著高于按NACB标准区间(0.74-7.04 mIU/L)的3.00%(p<0.05)。
要点
- 参考人群血清TSH几何均数为2.28 mIU/L(2.5th-97.5th:0.74-7.04 mIU/L)。
- 参考人群中尿碘浓度升高与TSH第50和第97.5百分位升高、第2.5百分位降低显著相关。
- 按Roche区间诊断亚临床甲减患病率为13.61%,显著高于按NACB区间的3.00%(p<0.05)。
核心结论
- 血清TSH浓度随碘摄入增加而显著升高,因此建立TSH参考区间时必须考虑碘摄入。
- 为避免亚临床甲减的过度诊断和过度治疗,不同地区应使用各自的血清TSH参考区间。
研究设计与样本
- 研究数据来自中国全国代表性横断面研究(TIDE研究),共纳入78,470名参与者。
- 总研究人群为TIDE项目参与者,参考人群为按美国国家临床生物化学学院(NACB)指南定义的总人群子集。
- 检测了甲状腺激素、TSH、甲状腺抗体和尿碘浓度(UIC)的血清浓度。
主要发现
- 参考人群和总人群的血清TSH几何均数(2.5th-97.5th)分别为2.28 mIU/L(0.74-7.04 mIU/L)和2.34 mIU/L(0.61-8.33 mIU/L)。
- 参考人群中,UIC升高与TSH第50和第97.5百分位升高、第2.5百分位降低显著相关。
- 女性TSH中位数显著高于男性(2.41 mIU/L vs. 2.16 mIU/L,p<0.001)。
- 年龄增加与TSH第97.5百分位升高显著相关;人群年龄每增加10岁,TSH第97.5百分位升高0.534 mIU/L。
- TIDE研究中按试剂推荐区间(Roche 0.27-4.2 mIU/L)和NACB标准区间(0.74-7.04 mIU/L)诊断的亚临床甲减患病率差异显著(Roche 13.61% vs. TIDE 3.00%,p<0.05)。
关键数值与推荐
- 参考人群血清TSH几何均数(2.5th-97.5th)为2.28 mIU/L(0.74-7.04 mIU/L)。
- 总人群血清TSH几何均数(2.5th-97.5th)为2.34 mIU/L(0.61-8.33 mIU/L)。
- 女性TSH中位数2.41 mIU/L vs. 男性2.16 mIU/L(p<0.001)。
- 人群年龄每增加10岁,TSH第97.5百分位升高0.534 mIU/L。
- 亚临床甲减患病率:Roche区间(0.27-4.2 mIU/L)13.61% vs. NACB区间(0.74-7.04 mIU/L)3.00%(p<0.05)。
临床怎么用
- 建立血清TSH参考区间时应考虑碘摄入情况。
- 不同地区应使用各自的血清TSH参考区间,以避免亚临床甲减的过度诊断和过度治疗。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Subclinical hypothyroidism is diagnosed based on serum thyrotropin (TSH) reference intervals, which in turn are affected by many factors. Methods: Data were acquired from a Chinese nationally representative cross-sectional study of 78,470 participants (TIDE study). The total study population were participants from the TIDE program, and the reference population was a subset of the total population defined by the National Academy of Clinical Biochemistry (NACB) guidelines. Serum concentrations of thyroid hormones, TSH, thyroid antibodies, and urine iodine concentration (UIC) were measured. Results: The geometric mean serum TSH (2.5th-97.5th) for the reference population (defined by the NACB) and total population was 2.28 mIU/L (0.74-7.04 mIU/L) and 2.34 mIU/L (0.61-8.33 mIU/L), respectively. In the reference population, increase in UIC was significantly associated with increase in the 50th and 97.5th centiles and decrease in the 2.5th centile of TSH. The median TSH was significantly higher in women than in men (2.41 mIU/L vs. 2.16 mIU/L, p-value <0.001). Increased age was significantly associated with an increased TSH, 97.5th centile. For each 10-year increase in the population age, the TSH 97.5th centile increased by 0.534 mIU/L. The prevalence of subclinical hypothyroidism diagnosed according to the assay-recommended interval (Roche 0.27-4.2 mIU/L) and NACB standard interval in the TIDE study (0.74-7.04 mIU/L) differed significantly (Roche 13.61% vs. TIDE 3.00%, p < 0.05). However, there was no significant difference in future cardiovascular disease, reflected by the Framingham risk score, between the 0.27-4.2 and 4.2-7.04 mIU/L TSH groups. Conclusions: Serum TSH concentration significantly increased with increase in iodine intake. Thus, iodine intake must be considered in establishing TSH reference intervals. To avoid overdiagnosis and overtreatment of subclinical hypothyroidism, different areas should use individual serum TSH reference intervals.
引用
- Zhao L, Teng D, Shi X, et al. The Effect of Increased Iodine Intake on Serum Thyrotropin: A Cross-Sectional, Chinese Nationwide Study. Thyroid. 2020. PMID: 32762331. doi:10.1089/thy.2019.0842
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。